9,540 Shares in Intuitive Surgical, Inc. (NASDAQ:ISRG) Acquired by Sava Infond d.o.o.

Sava Infond d.o.o. purchased a new stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) during the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm purchased 9,540 shares of the medical equipment provider's stock, valued at approximately $4,979,000. Intuitive Surgical comprises about 0.9% of Sava Infond d.o.o.'s portfolio, making the stock its 21st biggest holding.

Other large investors have also recently made changes to their positions in the company. Atala Financial Inc bought a new stake in Intuitive Surgical during the fourth quarter valued at approximately $25,000. Berbice Capital Management LLC purchased a new stake in Intuitive Surgical in the fourth quarter worth about $26,000. BankPlus Trust Department bought a new position in shares of Intuitive Surgical in the fourth quarter worth about $28,000. Kohmann Bosshard Financial Services LLC bought a new position in shares of Intuitive Surgical during the 4th quarter valued at approximately $31,000. Finally, Decker Retirement Planning Inc. purchased a new stake in Intuitive Surgical in the 4th quarter worth approximately $36,000. 83.64% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

Several equities analysts have weighed in on ISRG shares. CICC Research started coverage on shares of Intuitive Surgical in a report on Monday, January 27th. They set a "neutral" rating and a $550.00 price target on the stock. UBS Group increased their price target on Intuitive Surgical from $500.00 to $560.00 and gave the stock a "neutral" rating in a research note on Monday, January 27th. Jefferies Financial Group boosted their price objective on Intuitive Surgical from $475.00 to $575.00 in a research report on Monday, January 27th. Bernstein Bank increased their target price on Intuitive Surgical from $655.00 to $700.00 and gave the stock an "overweight" rating in a research report on Monday, January 27th. Finally, Barclays boosted their price target on Intuitive Surgical from $610.00 to $674.00 in a report on Monday, January 27th. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and fifteen have issued a buy rating to the company's stock. According to MarketBeat, the stock presently has an average rating of "Moderate Buy" and a consensus target price of $611.86.

Remove Ads

Intuitive Surgical Price Performance

Shares of ISRG traded down $2.73 during midday trading on Monday, hitting $489.12. The stock had a trading volume of 678,267 shares, compared to its average volume of 1,523,849. The stock's 50 day moving average is $556.28 and its 200 day moving average is $532.97. The firm has a market cap of $174.21 billion, a PE ratio of 76.41, a price-to-earnings-growth ratio of 5.85 and a beta of 1.43. Intuitive Surgical, Inc. has a 1 year low of $364.17 and a 1 year high of $616.00.

Insider Buying and Selling

In other Intuitive Surgical news, VP Fredrik Widman sold 810 shares of the company's stock in a transaction on Monday, March 3rd. The stock was sold at an average price of $573.78, for a total value of $464,761.80. Following the transaction, the vice president now owns 473 shares of the company's stock, valued at $271,397.94. This represents a 63.13 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, EVP Robert Desantis sold 11,545 shares of Intuitive Surgical stock in a transaction on Thursday, March 13th. The stock was sold at an average price of $499.22, for a total value of $5,763,494.90. Following the sale, the executive vice president now owns 5,224 shares of the company's stock, valued at approximately $2,607,925.28. This trade represents a 68.85 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 33,754 shares of company stock valued at $17,691,621 in the last ninety days. 0.70% of the stock is owned by company insiders.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.